<DOC>
	<DOCNO>NCT00361283</DOCNO>
	<brief_summary>The purpose study test whether atorvastatin ( also know Lipitor ) anti-inflammatory effect people know heart disease high cholesterol . We also investigate whether genetic difference people play role drug response .</brief_summary>
	<brief_title>Systemic Immunomodulatory Effects Pharmacogenetics Atorvastatin Early Atherosclerosis</brief_title>
	<detailed_description>All subject receive 16 week Atorvastatin two week run . Key dependent variable 16 week value minus baseline value ( post run-in ) . Last observation carry forward use miss value . The key comparison two group OATP1B1 reduce carrier on-carriers association Cytokines Lipids . Secondarily , interested change 16 week pool sample , irrespective genetics .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>18+ year old Normocholesterolemic Cardiovascular disease risk equivalent Malignancy Active alcohol abuse Contraindications statins Interacting drug Chronic antiinflammatory drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>